An unusual presentation of pheochromocytoma

NDT Plus

Volumn 4, Issue 5, 2011, Pages 331-334

  Taliercio, Jonathan J ^a   Bravo, Emmanuel ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

glucocorticoid administration; lactic acidosis; myocarditis; pheochromocytoma

Indexed keywords

AMLODIPINE; ANTIHISTAMINIC AGENT; DOXAZOSIN; ENALAPRILAT; GLYCERYL TRINITRATE; HYDROCORTISONE; METOPROLOL; METOPROLOL SUCCINATE; NORADRENALIN; VASOPRESSIN;

ABNORMAL RESPIRATORY SOUND; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ALLERGIC REACTION; ARTICLE; CASE REPORT; CONTRAST INDUCED NEPHROPATHY; DIAPHORESIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FACE RASH; FEMALE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOTENSION; LIVER HEMANGIOMA; LUNG EDEMA; LUNG EMBOLISM; LUNG INFILTRATE; METABOLIC ACIDOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PRURITUS; RESPIRATORY ACIDOSIS; RESPIRATORY DISTRESS; SINUS TACHYCARDIA; URTICARIA;

EID: 80053420810     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr055     Document Type: Article

References (14)

1. Lindley SE, She X, Schatzberg AF. Monoamine oxidase and catechol-omethyltransferase enzyme activity and gene expression in response to sustained glucocorticoids. Psychoneuroendocrinology 2005; 8: 785-790. (Pubitemid 40775745)
2. Sharara-Chami RI, Joachim M, Pacak K et al. Glucocorticoid treatment-effect on adrenal medullary catecholamine production. Shock 2009; 34: 40-43.
3. Goodman R, Edgar H, Thoenen H et al. Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma Metabolism 2002; 51: 11-14.
4. Madias NE, GoornoWE, Herson S. Severe lactic acidosis as a presenting feature of pheochromocytoma. Am J Kidney Dis 1987; 3: 250-253.
5. Takeshita T, Shima H, Oishi S et al. Noncardiogenic pulmonary edema as the first manifestation of pheochromocytoma: a case report. Radiat Med 2005; 2: 133-138.
6. Rassler B. The role of catecholamines in formation and resolution of pulmonary edema. Cardiovasc Haematol Disord Drug Targets 2007; 7: 27-53.
7. Jategaonkar SR, Butz T, Burchert W et al. Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma. Clin Res Cardiol 2009; 98: 195-198.
8. Wu XM, Chen JJ, Wu CK et al. Pheochromocytoma presenting as acute myocarditis with cardiogenic shock in two cases. Intern Med 2008; 47: 2151-2155.
9. Rossi AP, Bing-You RG, Thomas LR. Recurrent tako-tsubo cardiomyopathy associated with pheochromocytoma: a case report. Endocr Pract 2009; 2: 1-11.
10. Behonick GS, Novak MJ, Nealley EW et al. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J Appl Toxicol, 2001; 21: 15-22.
11. Boulmier D, Bazin P. Myocardial pseudo-infarction: ''stress''-associated catecholamine-induced acute cardiomyopathy or coronary spasm? Ann Cardiol Angeiol (Paris) 2000; 49: 449-454.
12. Anaforoglu I, Ertorer ME, Haydardedeoglu FE et al. Rhabdomyolysis and acute myoglobinuric renal failure in a patient with bilateral pheochromocytomafollowing open pyelolithotomy. South Med J 2008; 101: 354-355.
13. DiBona G. Neural control of the kidney. Past, present and future. Hypertension 2003; 43: 147-150.
14. Golden S, Robinson K, Saldanha I et al. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin EndocrinolMetab 2009; 94: 1853-1879.